Why the study?
Polymorbidity and polypharmacy predispose ACS patients to medication discrepancies, drug-related problems, and inadequate adherence, prompting an evaluation of clinical pharmacist-provided services on patient outcomes.
Does the addition of clinical pharmacist-provided services to standard medical care reduce drug-related problems and improve clinical parameters in ACS patients undergoing cardiac rehabilitation?
Comparison
Standard medical care plus clinical pharmacist-provided services vs standard medical care alone
Design
Prospective randomized controlled study
Follow-up
3 months
Authors
Loading...
Supports integrating clinical pharmacists into ACS cardiac rehabilitation; extends RCT evidence for pharmacist-led secondary prevention.
Does the addition of clinical pharmacist-provided services to standard medical care reduce drug-related problems and improve clinical parameters in ACS patients undergoing cardiac rehabilitation?
The integration of clinical pharmacists into cardiac rehabilitation programs for ACS patients significantly reduces drug-related problems and improves medication adherence, patient knowledge, and cardiovascular risk factors.
Casper et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: